Tonix Pharmaceuticals (TNXP) announced it has been awarded a grant from the Medical CBRN Defense Consortium, MCDC, to support the development of TNX-801. MCDC is a consortium of industrial ...

Craig-Hallum analyst Chase Knickerbocker lowered the firm’s price target on Phathom Pharmaceuticals (PHAT) to $19 from $27 and keeps a Buy rating on the shares. The firm notes Phathom’s Q4 ...

A backlog of delayed projects led to a record 148.1% surge in 2023, raising new capacity to 216.88 GW. Despite this, 2024 saw further growth, with installations up 28.3% to 277.57 GW, pushing ...

In 2021, the company acquired GW Pharmaceuticals for $7.2bn, gaining the seizure medication Epidiolex (cannabidiol). In February 2024, it licensed a KRAS inhibitor programme from UK-based Redx ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical ...

Jazz has also been developing Ziihera for HER2-positive breast and gastric cancers. In 2021, the company acquired GW Pharmaceuticals for $7.2bn, gaining the seizure medication Epidiolex (cannabidiol).

Global offshore wind is gearing up for a comeback in 2025, with new capacity additions expected to hit 19 gigawatts (GW) and spending projected to soar to $80 billion, according to Oslo-based ...

JSW Energy's acquisition of assets from O2 Power and Hetero Group, along with a thermal power asset, has increased its capacity to meet a 20 GW target by 2028, two years ahead of schedule. The company ...